Missouri Autism Centers of Excellence Collaborative (MACEC): SEED Early Development Study
Project Number5U01DD001216-05
Contact PI/Project LeaderCONSTANTINO, JOHN N.
Awardee OrganizationWASHINGTON UNIVERSITY
Description
Abstract Text
Abstract
This project is a focused on the continuation of the epidemiological research
capability of the Centers for Autism and Developmental Disabilities Epidemiology
(CADDRE) network with implementation of Phase 3 of the Study to Explore Early
Development. The ongoing objectives of the SEED study are to characterize the autism
behavioral phenotype and associated developmental, medical and behavioral conditions
of autism. and to understand the genetic and environmental risk factors of Autism. The
aims of this application are as follows: 1. Implement a third Phase of the SEED study
preserving the core study design with enhancements to improve recruitment and a
reduction in the data collection protocol in a new Midwestern SEED site. The following
aspects of the core study design will be preserved in Phase 3: a) a case-control study
design with multiple- source ascertainment of an ASD case group, a non- ASD
developmental disability (DD) comparison group and a population-based (POP)
comparison group, b) clinical confirmation of developmental status of all participants
using a standardized assessment protocol, and c) collection of clinical, genetic and
environmental data. Recruitment enhancements will include active follow-up
procedures for invited participants. Data collection will be streamlined, compared to
Phase 2, primarily by eliminating pediatric and neonatal medical record abstraction for
all three participant groups and curtailing data collected for the DD comparison group.
2. Further increase the total SEED pooled sample size to enhance SEED's analytic
potential to investigate rare exposures and ASD subtypes by achieving complete data
collection on 125 ASD children, 125 DD children and 125 POP children within our site.
Reaching these targets at all anticipated Phase 3 sites will increase the total SEED ASD
sample to approximately 2000 children which will enhance the examination of rare
exposures and modest associations potentially relevant to the etiology of ASD.
Public Health Relevance Statement
Project Narrative
This project is a focused on the continuation of the epidemiological research capability
of the Centers for Autism and Developmental Disabilities Epidemiology (CADDRE)
network with implementation of Phase 3 of the Study to Explore Early Development.
The ongoing objectives of the SEED study are to characterize the autism behavioral
phenotype and associated developmental, medical and behavioral conditions of autism.
and to understand the genetic and environmental risk factors of Autism.
National Center on Birth Defects and Developmental Disabilities
CFDA Code
283
DUNS Number
068552207
UEI
L6NFUM28LQM5
Project Start Date
01-July-2016
Project End Date
30-June-2021
Budget Start Date
01-July-2020
Budget End Date
30-June-2021
Project Funding Information for 2020
Total Funding
$770,377
Direct Costs
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2020
National Center on Birth Defects and Developmental Disabilities
$770,377
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U01DD001216-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U01DD001216-05
Patents
No Patents information available for 5U01DD001216-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U01DD001216-05
Clinical Studies
No Clinical Studies information available for 5U01DD001216-05
News and More
Related News Releases
No news release information available for 5U01DD001216-05
History
No Historical information available for 5U01DD001216-05
Similar Projects
No Similar Projects information available for 5U01DD001216-05